Cargando…
Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy
Atorvastatin is the most commonly used statin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920241/ https://www.ncbi.nlm.nih.gov/pubmed/33659112 http://dx.doi.org/10.7759/cureus.12957 |
_version_ | 1783658235613413376 |
---|---|
author | Boppana, Sri Harsha Syed, Hasan A Antwi-Amoabeng, Daniel Reddy, Prahlad Gullapalli, Nageshwara |
author_facet | Boppana, Sri Harsha Syed, Hasan A Antwi-Amoabeng, Daniel Reddy, Prahlad Gullapalli, Nageshwara |
author_sort | Boppana, Sri Harsha |
collection | PubMed |
description | Atorvastatin is the most commonly used statin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from simple reversible myalgia to respiratory muscle compromise. Here we present a 46-year-old male who presented with myopathy after taking atorvastatin for two years. Biopsy proved immune-mediated necrotizing myopathy which responded to a combination of Rituximab and intravenous immunoglobulin therapy. |
format | Online Article Text |
id | pubmed-7920241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-79202412021-03-02 Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy Boppana, Sri Harsha Syed, Hasan A Antwi-Amoabeng, Daniel Reddy, Prahlad Gullapalli, Nageshwara Cureus Internal Medicine Atorvastatin is the most commonly used statin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from simple reversible myalgia to respiratory muscle compromise. Here we present a 46-year-old male who presented with myopathy after taking atorvastatin for two years. Biopsy proved immune-mediated necrotizing myopathy which responded to a combination of Rituximab and intravenous immunoglobulin therapy. Cureus 2021-01-28 /pmc/articles/PMC7920241/ /pubmed/33659112 http://dx.doi.org/10.7759/cureus.12957 Text en Copyright © 2021, Boppana et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Boppana, Sri Harsha Syed, Hasan A Antwi-Amoabeng, Daniel Reddy, Prahlad Gullapalli, Nageshwara Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title | Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title_full | Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title_fullStr | Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title_full_unstemmed | Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title_short | Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy |
title_sort | atorvastatin-induced necrotizing myopathy and its response to combination therapy |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920241/ https://www.ncbi.nlm.nih.gov/pubmed/33659112 http://dx.doi.org/10.7759/cureus.12957 |
work_keys_str_mv | AT boppanasriharsha atorvastatininducednecrotizingmyopathyanditsresponsetocombinationtherapy AT syedhasana atorvastatininducednecrotizingmyopathyanditsresponsetocombinationtherapy AT antwiamoabengdaniel atorvastatininducednecrotizingmyopathyanditsresponsetocombinationtherapy AT reddyprahlad atorvastatininducednecrotizingmyopathyanditsresponsetocombinationtherapy AT gullapallinageshwara atorvastatininducednecrotizingmyopathyanditsresponsetocombinationtherapy |